<DOC>
	<DOCNO>NCT02431741</DOCNO>
	<brief_summary>This prospective , open , non-controlled clinical investigation evaluate performance safety use Mepilex Transfer Ag malignant wound . Approximately ten fifteen ( 10-15 ) subject one three center Europe , present malignant ( fungating ) wound enrol study . Eligible subject one malignant ( fungating ) wound select `` study site '' . Subjects follow one-week observation period exist product follow 4-week investigation period use Mepilex Transfer Ag .</brief_summary>
	<brief_title>A Prospective , Open , Non-controlled Clinical Investigation Evaluate Performance Safety Antimicrobial Foam Transferring Dressing Patients With Malignant Wounds</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Presence least one exude malignant ( fungating ) wound need antimicrobial treatment Both gender age â‰¥ 18 year randomization Subjects suspect survival time &gt; 3 month Signed informed consent Any know suspected systemic infection Use metronidazole allow investigation period Any known sensitivity silver components/products use study . Major uncontrolled systemic disorder hepatic , renal , neurologic , endocrinologic disorder . Participation another investigational study participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Presence least one exude malignant ( fungating ) wound need antimicrobial treatment</keyword>
</DOC>